Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |